Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

Jonas Hugosson, Hans Lilja, Pär Lodding, Carl Gustav Pihl

Research output: Contribution to journal › Article › peer-review

Subject classification (UKÄ)

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d639e3c5e52e42829c89ef34bfb48380,

title = "Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers",

author = "Jonas Hugosson and Hans Lilja and P{\"a}r Lodding and Pihl, {Carl Gustav}",

year = "2001",

doi = "10.1159/000052582",

language = "English",

volume = "39",

pages = "33--34",

journal = "European Urology",

issn = "1873-7560",

publisher = "Elsevier",

number = "Suppl 4",

}

TY - JOUR

T1 - Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

AU - Hugosson, Jonas

AU - Lilja, Hans

AU - Lodding, Pär

AU - Pihl, Carl Gustav

PY - 2001

Y1 - 2001

U2 - 10.1159/000052582

DO - 10.1159/000052582

M3 - Article

SN - 1873-7560

VL - 39

SP - 33

EP - 34

JO - European Urology

JF - European Urology

IS - Suppl 4

ER -